{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:25:33Z","timestamp":1760239533908,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15SDG25880000"],"award-info":[{"award-number":["15SDG25880000"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R15HL127596","1R01EB028798"],"award-info":[{"award-number":["1R15HL127596","1R01EB028798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The purpose of this pilot study was to investigate the feasibility of a perfusion catheter to deliver liquid paclitaxel into arterial segments. A clinically relevant rabbit ilio-femoral injury model was utilized to determine the impact of liquid paclitaxel delivered locally into the vessel wall using a perfusion catheter at 1 h to 14 days. Treatment by two clinically available forms of liquid paclitaxel, a solvent-based (sb) versus an albumin-bound (nab), along with a control (uncoated balloons), were investigated. Pharmacokinetic results demonstrated an increase in the retention of the sb-paclitaxel versus the nab-paclitaxel at 1 h; however, no other differences were observed at days one, three, and seven. Histological findings at 14 days showed significantly less neointimal area in the sb-paclitaxel treated arteries as compared with the nab-paclitaxel and the uncoated balloon-treated arteries. Additionally, percent area stenosis was significantly less in the sb-paclitaxel group. These results support the concept of local liquid delivery of paclitaxel into the arterial segments.<\/jats:p>","DOI":"10.3390\/ph13120434","type":"journal-article","created":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T21:00:57Z","timestamp":1606683657000},"page":"434","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pre-Clinical Investigation of Liquid Paclitaxel for Local Drug Delivery: A Pilot Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-5479","authenticated-orcid":false,"given":"Claire V.","family":"Cawthon","sequence":"first","affiliation":[{"name":"Department of Mechanical Engineering, University of South Alabama, Mobile, AL 36688, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2569-9693","authenticated-orcid":false,"given":"Kathryn","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Mechanical Engineering, University of South Alabama, Mobile, AL 36688, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifton","family":"Huett","sequence":"additional","affiliation":[{"name":"Department of Mechanical Engineering, University of South Alabama, Mobile, AL 36688, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Lloret","sequence":"additional","affiliation":[{"name":"Department of Engineering, Wake Forest University, Winston-Salem, NC 27101, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estefanny","family":"Villar-Matamoros","sequence":"additional","affiliation":[{"name":"Department of Engineering, Wake Forest University, Winston-Salem, NC 27101, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Stokes","sequence":"additional","affiliation":[{"name":"Department of Engineering, Wake Forest University, Winston-Salem, NC 27101, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Christians","sequence":"additional","affiliation":[{"name":"iC42 Clinical Research and Development, University of Colorado, Aurora, CO 80045, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Schuler","sequence":"additional","affiliation":[{"name":"Department of Comparative Medicine, University of South Alabama, Mobile, AL 36688, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9719-6382","authenticated-orcid":false,"given":"Saami K.","family":"Yazdani","sequence":"additional","affiliation":[{"name":"Department of Engineering, Wake Forest University, Winston-Salem, NC 27101, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e169-72","DOI":"10.1161\/01.CIR.0000160581.58633.8B","article-title":"Cardiology patient page. Peripheral arterial disease","volume":"111","author":"Gornik","year":"2005","journal-title":"Circulation"},{"key":"ref_2","first-page":"207","article-title":"The \u201cDEBELLUM\u201d\u2014Lower limb multilevel treatment with drug eluting balloon\u2014Randomized trial: 1-year results","volume":"55","author":"Fanelli","year":"2014","journal-title":"J. Cardiovasc. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/hc4201.098056","article-title":"Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up","volume":"104","author":"Sousa","year":"2001","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"key":"ref_5","first-page":"E7","article-title":"Role of nitinol stent fractures in the development of in-stent restenosis in the superficial femoral artery","volume":"1","author":"Babaev","year":"2016","journal-title":"Vasc. Dis. Manag."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1526602815580783","article-title":"Stent fractures after superficial femoral artery stenting: Risk factors and impact on patency","volume":"22","author":"Lin","year":"2015","journal-title":"J Endovasc."},{"key":"ref_7","first-page":"325","article-title":"Femoropopliteal in-stent restenosis: Current treatment strategies","volume":"55","author":"Singh","year":"2014","journal-title":"J. Cardiovasc. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejvs.2013.05.010","article-title":"Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year","volume":"46","author":"Davaine","year":"2013","journal-title":"Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Desyatova, A., Poulson, W., Deegan, P., Lomneth, C., Seas, A., Maleckis, K., MacTaggart, J., and Kamenskiy, A. (2017). Limb flexion-induced twist and associated intramural stresses in the human femoropopliteal artery. J. R. Soc. Interface, 14.","DOI":"10.1098\/rsif.2017.0025"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.jbiomech.2014.04.053","article-title":"Three-dimensional bending, torsion and axial compression of the femoropopliteal artery during limb flexion","volume":"47","author":"MacTaggart","year":"2014","journal-title":"J. Biomech."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10439-018-1990-1","article-title":"Nitinol stents in the femoropopliteal artery: A mechanical perspective on material, design, and performance","volume":"46","author":"Maleckis","year":"2018","journal-title":"Ann. Biomed. Eng."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","article-title":"Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery","volume":"96","author":"Axel","year":"1997","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCINTERVENTIONS.111.967794","article-title":"Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel?","volume":"5","author":"Speck","year":"2012","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: A systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jvir.2019.11.015","article-title":"Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: A systematic review and meta-analysis of randomized controlled trials","volume":"31","author":"Katsanos","year":"2020","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jvs.2019.05.002","article-title":"Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease","volume":"70","author":"Mills","year":"2019","journal-title":"J. Vasc. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jvir.2018.07.025","article-title":"Comparison of biologic effect and particulate embolization after femoral artery treatment with three drug-coated balloons in healthy swine model","volume":"30","author":"Torii","year":"2019","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jvir.2016.06.036","article-title":"Comparison of particulate embolization after femoral artery treatment with IN.PACT admiral versus Lutonix 035 paclitaxel-coated balloons in healthy swine","volume":"27","author":"Kolodgie","year":"2016","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2165\/00003088-199427040-00002","article-title":"Clinical pharmacokinetics of paclitaxel","volume":"27","author":"Sonnichsen","year":"1994","journal-title":"Clin. Pharmacokinet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jcin.2015.03.020","article-title":"Impact of paclitaxel dose on tissue pharmacokinetics and vascular healing: A comparative drug-coated balloon study in the familial hypercholesterolemic swine model of superficial femoral in-stent restenosis","volume":"8","author":"Gongora","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e000117","DOI":"10.1136\/openhrt-2014-000117","article-title":"Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: Impact on neointimal proliferation and healing","volume":"1","author":"Granada","year":"2014","journal-title":"Open Heart"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"eaaw6081","DOI":"10.1126\/sciadv.aaw6081","article-title":"Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy","volume":"5","author":"Sasaki","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_26","first-page":"1237","article-title":"Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel","volume":"8","author":"Gelderblom","year":"2002","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Atigh, M.K., Turner, E., Christians, U., and Yazdani, S.K. (2017). The use of an occlusion perfusion catheter to deliver paclitaxel to the arterial wall. Cardiovasc, 35.","DOI":"10.1111\/1755-5922.12269"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3389\/fphar.2018.00808","article-title":"In vitro and in vivo Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons","volume":"9","author":"Turner","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s13239-018-0346-1","article-title":"Coating and pharmacokinetic evaluation of air spray coated drug coated balloons","volume":"9","author":"Turner","year":"2018","journal-title":"Cardiovasc. Eng. Technol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ccd.24995","article-title":"Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model","volume":"83","author":"Yazdani","year":"2014","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_31","first-page":"383","article-title":"Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents","volume":"25","author":"Yazdani","year":"2013","journal-title":"J. Invasive Cardiol"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Goel, E., Erwin, M., Cawthon, C.V., Schaff, C., Fedor, N., Rayl, T., Wilson, O., Christians, U., Register, T.C., and Geary, R.L. (2020). Pre-clinical investigation of keratose as an excipient of drug coated balloons. Molecules, 25.","DOI":"10.3390\/molecules25071596"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/13\/12\/434\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:38:53Z","timestamp":1760179133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/13\/12\/434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ph13120434"],"URL":"https:\/\/doi.org\/10.3390\/ph13120434","relation":{},"ISSN":["1424-8247"],"issn-type":[{"type":"electronic","value":"1424-8247"}],"subject":[],"published":{"date-parts":[[2020,11,28]]}}}